Literature DB >> 24470462

Is natriuretic peptide receptor C a new target for hypertension therapeutics?

Yanfei Qi1, Mohan K Raizada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24470462      PMCID： PMC3966087          DOI： 10.1161/HYPERTENSIONAHA.113.02702

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  9 in total

1.  Sustained blood pressure-lowering actions of subcutaneous B-type natriuretic peptide (nesiritide) in a patient with uncontrolled hypertension.

Authors:  Alessandro Cataliotti; Lisa C Costello-Boerrigter; Horng H Chen; Stephen C Textor; John C Burnett
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

2.  Physiological role of silent receptors of atrial natriuretic factor.

Authors:  T Maack; M Suzuki; F A Almeida; D Nussenzveig; R M Scarborough; G A McEnroe; J A Lewicki
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

Review 3.  Natriuretic peptide C receptor signalling in the heart and vasculature.

Authors:  Robert A Rose; Wayne R Giles
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

4.  Peptide-based nanoparticle for ex vivo and in vivo drug delivery.

Authors:  Laurence Crombez; May Catherine Morris; Sebastien Deshayes; Frederic Heitz; Gilles Divita
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

5.  Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice.

Authors:  Dheeraj Verma; Babak Moghimi; Paul A LoDuca; Harminder D Singh; Brad E Hoffman; Roland W Herzog; Henry Daniell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

6.  Variable number of tandem repeat of the 5'-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension.

Authors:  Noriko Aoi; Masayoshi Soma; Tomohiro Nakayama; Dolkun Rahmutula; Kotoko Kosuge; Yoichi Izumi; Koichi Matsumoto
Journal:  Hypertens Res       Date:  2004-10       Impact factor: 3.872

7.  Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system.

Authors:  M B Anand-Srivastava; M R Sairam; M Cantin
Journal:  J Biol Chem       Date:  1990-05-25       Impact factor: 5.157

8.  Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension.

Authors:  Alessandro Cataliotti; Horng H Chen; John A Schirger; Fernando L Martin; Guido Boerrigter; Lisa C Costello-Boerrigter; Kenneth D James; Karen Polowy; Mark A Miller; Navdeep B Malkar; Kent R Bailey; John C Burnett
Journal:  Circulation       Date:  2008-10-06       Impact factor: 29.690

Review 9.  Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics.

Authors:  Sarah Mangiafico; Lisa C Costello-Boerrigter; Ingrid A Andersen; Alessandro Cataliotti; John C Burnett
Journal:  Eur Heart J       Date:  2012-08-31       Impact factor: 29.983
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.